Large funding rounds help boost digital health investment in H1

Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.

Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.

Elevance will leave D.C. this summer and is considering other markets to depart, executives said. The company outperformed Wall Street expectations in the second quarter — but not by much, and its stock fell accordingly.

A federal judge dismissed another lawsuit brought by an Elevance health plan alleging the billings intermediary was gaming the arbitration process set up by the No Surprises Act.

Physician groups said the sweeping rule is a double-edged sword, given it includes an unwelcome fee cut but positive changes to Medicare’s value-based and quality payment programs.
Amanda Chawla comes to the Washington-based nonprofit giant from Stanford Medicine. Providence is hoping her appointment will bolster its supply chain capabilities during a time of elevated spend.

Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost versions of drugs on standard formularies.

SCAN Health Plan and Alignment Healthcare both filed lawsuits against the CMS last week after regulators refused to recalculate industry-wide MA scores using the same methodology as for Clover Health.

Payer mix changes, mostly from people dropping out of Affordable Care Act plans, caused HCA to lose $400 million in the second quarter — much more than the company (or its investors) had expected.

Hospitals and health systems recorded 18 transactions in the second quarter after a lull in dealmaking early last year as providers look to partner up to bolster their finances.

The HHS Office of Inspector General said it had kicked over 1,200 people and entities off federal programs between October and March as the Trump administration ratchets up oversight into what it says is rampant fraud in healthcare.